NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Addressing the Barriers to Pediatric Drug Development

Addressing the Barriers to Pediatric Drug Development

Workshop Summary


Washington (DC): National Academies Press (US); .
ISBN-13: 978-0-309-10742-6ISBN-10: 0-309-10742-3


The purpose of the workshop was to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children. The Forum invited representatives from the U.S. Food and Drug Administration (FDA), the National Institutes of Health, the American Academy of Pediatrics, the pharmaceutical industry, academia, and several patient advocacy groups to discuss: the current regulatory framework; current challenges in prescribing and developing drugs for children; models for enhancing pediatric drug development; and challenges and opportunities for the future.


Cori Vanchieri and Adrienne Stith Butler, Rapporteurs.

Support for this project was provided by the Department of Health and Human Services (Contract Nos. 223-01-2460, HHSP233200600500P, HHSPP23320042509X1, and N01-OD-4-2139); the Department of Veterans Affairs (Contract No. V101(93)P- 2136); Abbott Laboratories; American Diabetes Association; American Society for Microbiology; Amgen, Inc.; Association of American Medical Colleges; Astra- Zeneca Pharmaceuticals; Blue Cross Blue Shield Association; Burroughs Wellcome Fund; Doris Duke Charitable Foundation; Eli Lilly and Company; Entelos, Inc.; Genentech; GlaxoSmithKline; Johnson & Johnson; March of Dimes Foundation; Merck and Company; Pfizer, Inc.; Schering-Plough Research Institute; and UnitedHealth Foundation. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

Suggested citation:

IOM (Institute of Medicine). 2008. Addressing the barriers to pediatric drug development: Workshop summary. Washington, DC: The National Academies Press.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Copyright © 2008, National Academy of Sciences.
Bookshelf ID: NBK3994PMID: 20669414DOI: 10.17226/11911


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (487K)

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...